Spartina Biotechnologies

A New Way To
Treat Viral Infections

Introducing SIRENTM 
An innovative technology that blocks replication of the virus that causes COVID-19.

Spartina Biotechnologies is an early-stage biotech company that is developing and implementing a platform (SIREN™) for precision delivery of RNA molecules to specific cells and organs, beginning with RNAi molecules to destroy the SARS-CoV-2 virus genome. By its nature, SIREN™ will deliver natural-like RNA molecules to all the organs that SARS-CoV-2 is able to infect and precisely destroy the virus’s RNA without affecting any human gene RNA, blocking further replication and spread of the virus.

The SIREN™ platform is poised to rapidly deploy to treat any emerging virus within a few months after discovery. SIREN™ can also treat numerous human diseases by silencing deleterious genes, thereby accelerating the RNA therapeutics industry.


Data is taken from official local sources and processed by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU).

120127 New Confirmed
175949107 Total Confirmed
2406 New Deaths
3806752 Total Deaths
90129 New Recovered
114195063 Total Recovered